← Eichor
Study identifier: NCT06530602 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

3-Dimensional Shoulder Complex Pain Alignment (3-D SPA) Mobilization on Frozen Shoulder.

Condition: Frozen Shoulder  ·  Sponsor: Riphah International University

PhaseNA
Planned participants36
Who can joinAll sexes, 40 Years to 65 Years
Healthy volunteersNo

About this study

Ongoing research aims to assess the enhancement of shoulder mobility by specifically addressing restrictions in all three planes of movement. current studies seek to investigate the impact of three-dimensional mobilization technique on their recovery and to prevent progression of disease to reduce pain, alleviate muscle tightness, facilitate tissue healing, and ultimately improve the range of motion in patients. A randomized control trial that will include total 36 participants. The first group will receive 3 Dimensional shoulder pain alignment (3-D SPA) mobilization along with conventional therapy and 2nd group will receive Shoulder mobilization along with conventional therapy. Data collected will be analyzed through SPSS 27.

This description comes directly from the study's public registry record.

Talk to the study team

Madiha Ali, MSOMPT  ·  0331-3360064  ·  madiha.ali@riphah.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Railway General HospitalRawalpindi, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06530602